X RAY GUIDED LASER THERAPY SYSTEM FOR BREAST CANCER

Information

  • Research Project
  • 2646457
  • ApplicationId
    2646457
  • Core Project Number
    R43CA074675
  • Full Project Number
    1R43CA074675-01A1
  • Serial Number
    74675
  • FOA Number
  • Sub Project Id
  • Project Start Date
    7/1/1998 - 26 years ago
  • Project End Date
    6/30/2000 - 24 years ago
  • Program Officer Name
    STONE, HELEN B.
  • Budget Start Date
    7/1/1998 - 26 years ago
  • Budget End Date
    6/30/2000 - 24 years ago
  • Fiscal Year
    1998
  • Support Year
    1
  • Suffix
    A1
  • Award Notice Date
    6/18/1998 - 26 years ago
Organizations

X RAY GUIDED LASER THERAPY SYSTEM FOR BREAST CANCER

We seek to develop a technique to treat breast cancer tumors in a minimally invasive way. The tumors would be eradicated using laser energy to photocoagulate the lesion through an incisionless interstitial approach. This approach will be enhanced by the capabilities of a high resolution X-ray, stereotactically guided, system that can accurately locate the lesion in 3 dimensions and deliver a trocar/cannulae to that exact location. After delivery of a specially designed laser energy transparent cannulae to the treatment site, laser energy will be uniformly diffused to treat the lesion with hyperthermia/coagulation. Laser probes will be miniaturized to minimize insertion trauma. This is a technologic approach to concern facing the 184,000 U.S. women yearly, with breast cancer, who live in dread of disfigurement from mastectomy and lumpectomy. We propose to: design, build and test a laser energy diffusing system capable of being stereotactically delivered to safely deliver the energy needed to coagulate clinically relevant tumors, examine the feasibility of monitoring the extent of the coagulated volume with the high resolution X-ray system already in use, and test the combined systems in an ex-vivo- and in-vivo model. PROPOSED COMMERCIAL APPLICATION The focus on the issue of breast cancer, from the mammogram to the possibility of mastectomy or lumpectomy, is one of today's highest health care concerns. A system that could locate and simultaneously treat breast cancer tumors in a minimally invasive way would have huge commercial application.

IC Name
NATIONAL CANCER INSTITUTE
  • Activity
    R43
  • Administering IC
    CA
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    395
  • Ed Inst. Type
  • Funding ICs
  • Funding Mechanism
  • Study Section
    ZRG7
  • Study Section Name
  • Organization Name
    CARDIOFOCUS, INC.
  • Organization Department
  • Organization DUNS
  • Organization City
    MARLBOROUGH
  • Organization State
    MA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    01752
  • Organization District
    UNITED STATES